Late Toxicities after Conventional Radiotherapy for Nasopharyngeal Carcinoma: Incidence and Risk Factors
Wicem Siala, Wafa Mnejja, Fatma Elloumi, Abdelmoneem Ghorbel, Jameleddine Mnif, Mounir Frikha, and Jamel Daoud 
Volume 2014 (2014), Article ID 268340, 8 pages

Is there any difference in therapeutic results of nasopharyngeal carcinoma between adults and children?.
Daoud J, Ghorbal L, Siala W, Elloumi F, Ghorbel A, Frikha M.
Cancer Radiother. 2013 Dec;17(8):763-7. doi: 10.1016/j.canrad.2013.06.046. Epub 2013 Nov 20. French.

Correlation between ebv co-infection and HPV16 genome integrity in Tunisian cervical cancer patients.
Kahla S, Oueslati S, Achour M, Kochbati L, Chanoufi MB, Maalej M, Oueslati R.
Braz J Microbiol. 2012 Apr;43(2):744-53. doi: 10.1590/S1517-83822012000200039. Epub 2012 Jun 1.

Esthesioneuroblastoma

Elloumi F, Boujelbene N, Ghorbal L, Boujelbene N, Khanfir K, Mirimanoff RO, Daoud J.
Bull Cancer. 2012 Dec;99(12):1197-207. doi: 10.1684/bdc.2012.1642. Review. French.

Post-radiation mucocele in two patients treated for nasopharyngeal cancer.
Mnejja M, Hammami B, Achour I, Chakroun A, Charfeddine I, Frikha M, Daoud J, Ghorbel A.
Cancer Radiother. 2011 Jun;15(3):254-6. doi: 10.1016/j.canrad.2010.12.004. Epub 2011 Mar 17. French.

XRCC1 and hOGG1 genes and risk of nasopharyngeal carcinoma in North African countries.
Laantri N, Jalbout M, Khyatti M, Ayoub WB, Dahmoul S, Ayad M, Bedadra W, Abdoun M, Mesli S, Kandil M, Hamdi-Cherif M, Boualga K, Bouaouina N, Chouchane L, Benider A, Ben-Ayed F, Goldgar D, Corbex M.
Mol Carcinog. 2011 Sep;50(9):732-7. doi: 10.1002/mc.20754. Epub 2011 Apr 22.

Lack of association between human leukocyte antigen-E alleles and nasopharyngeal carcinoma in Tunisians.
Hassen E, Ghedira R, Ghandri N, Farhat K, Gabbouj S, Bouaouina N, Abdelaziz H, Nouri A, Chouchane L.
DNA Cell Biol. 2011 Aug;30(8):603-9. doi: 10.1089/dna.2010.1140. Epub 2011 Feb 20.

Epstein-Barr virus DNA quantification and follow-up in Tunisian nasopharyngeal carcinoma patients.
Hassen E, Farhat K, Gabbouj S, Bouaouina N, Abdelaziz H, Chouchane L.
Biomarkers. 2011 May;16(3):274-80. doi: 10.3109/1354750X.2010.551409.

[Medical treatment of nasopharyngeal cancers].
Tebra S, Kallel A, Boussen H, Bouaouina N.
Tunis Med. 2011 Apr;89(4):326-31. Review. Italian.

Thyroid toxicity after radiotherapy of nasopharyngeal carcinoma.
Siala W, Mnejja W, Abid M, Ghorbel A, Frikha M, Daoud J.
Ann Endocrinol (Paris). 2011 Feb;72(1):19-23. doi: 10.1016/j.ando.2010.06.005. Epub 2010 Aug 19.

Association of HLA-G polymorphisms with nasopharyngeal carcinoma risk and clinical outcome.
Ghandri N, Gabbouj S, Farhat K, Bouaouina N, Abdelaziz H, Nouri A, Chouchane L, Hassen E.
Hum Immunol. 2011 Feb;72(2):150-8. doi: 10.1016/j.humimm.2010.10.006. Epub 2010 Oct 20.

Juvenile nasopharyngeal carcinoma: anatomoclinic, biologic, therapeutic and evolutive aspects.
Toumi N, Frikha M, Siala W, Khabir A, Karray H, Boudawara T, Gargouri RM, Ghorbel M, Daoud J.
Bull Cancer. 2010 Apr;97(4):427-33. doi: 10.1684/bdc.2010.1087. French.

Nasopharyngeal cancer (NPC) around the Mediterranean area: standard of care.
Boussen H, Ghorbal L, Naouel L, Bouaouina N, Gritli S, Benna F, Daoud J; Association of Radiotherapy and Oncology of the Mediterranean Area (AROME).
Crit Rev Oncol Hematol. 2012 Dec;84 Suppl 1:e106-9. doi: 10.1016/j.critrevonc.2010.09.005. Epub 2010 Dec 21. Review.

Epigenetic alteration of the Wnt inhibitory factor-1 promoter is common and occurs in advanced stage of Tunisian nasopharyngeal carcinoma.
Fendri A, Khabir A, Hadri-Guiga B, Sellami-Boudawara T, Daoud J, Frikha M, Ghorbel A, Gargouri A, Mokdad-Gargouri R.
Cancer Invest. 2010 Nov;28(9):896-903. doi: 10.3109/07357907.2010.494324.

A single nucleotide polymorphism in the E-cadherin gene promoter -160 C/A is associated with risk of nasopharyngeal cancer.
Ben Nasr H, Hamrita B, Batbout M, Gabbouj S, Bouaouina N, Chouchane L, Chahed K.
Clin Chim Acta. 2010 Sep 6;411(17-18):1253-7. doi: 10.1016/j.cca.2010.05.001. Epub 2010 May 9.

HLA association with nasopharyngeal carcinoma in southern Tunisia.
Makni H, Daoud J, Ben Salah H, Mahfoudh N, Haddar O, Karray H, Boudawara T, Ghorbel A, Khabir A, Frikha M.
Mol Biol Rep. 2010 Jun;37(5):2533-9. doi: 10.1007/s11033-009-9769-y. Epub 2009 Aug 28.

Acinic cell carcinoma of the nasal septum.
Hammami B, Dhouib H, Sallemi M, Ben Hmida A, Ben Mahfoudh K, Daoud J, Ghorbel A.
Rev Stomatol Chir Maxillofac. 2010 Apr;111(2):88-90. doi: 10.1016/j.stomax.2009.09.011. Epub 2009 Nov 25. French.

Update on medical therapies of nasopharyngeal carcinomas
Boussen H, Bouaouina N, Daldoul O, Benna F, Gritli S, Ladgham A.
Bull Cancer. 2010 Apr;97(4):417-26. doi: 10.1684/bdc.2010.1091. French.

Quality control of dosing delivered by in vivo measurements for head and neck radiotherapy.
Farhat L, Besbes M, Bridier A, Kaffel F, Daoud J.
Cancer Radiother. 2010 Jan;14(1):69-73. doi: 10.1016/j.canrad.2009.05.007. Epub 2009 Aug 19. French.

The human leukocyte antigen class I genes in nasopharyngeal carcinoma risk.
Hassen E, Nahla G, Bouaouina N, Chouchane L.
Mol Biol Rep. 2010 Jan;37(1):119-26. doi: 10.1007/s11033-009-9548-9. Epub 2009 May 17. Review.

PIK3CA amplification is predictive of poor prognosis in Tunisian patients with nasopharyngeal carcinoma.
Fendri A, Khabir A, Mnejja W, Sellami-Boudawara T, Daoud J, Frikha M, Ghorbel A, Gargouri A, Mokdad-Gargouri R.
Cancer Sci. 2009 Nov;100(11):2034-9. doi: 10.1111/j.1349-7006.2009.01292.x. Epub 2009 Jul 21.

Cannabis, tobacco and domestic fumes intake are associated with nasopharyngeal carcinoma in North Africa.
Feng BJ, Khyatti M, Ben-Ayoub W, Dahmoul S, Ayad M, Maachi F, Bedadra W, Abdoun M, Mesli S, Bakkali H, Jalbout M, Hamdi-Cherif M, Boualga K, Bouaouina N, Chouchane L, Benider A, Ben-Ayed F, Goldgar DE, Corbex M.
Br J Cancer. 2009 Oct 6;101(7):1207-12. doi: 10.1038/sj.bjc.6605281. Epub 2009 Sep 1.

IgA antibodies against the Epstein-Barr nuclear antigen1 as a valuable biomarker for the diagnosis of nasopharyngeal carcinoma in Tunisian patients.
Ayadi W, Karray-Hakim H, Feki L, Khabir A, Boudawara T, Ghorbel A, Daoud J, Frikha M, Hammami A.
J Med Virol. 2009 Aug;81(8):1412-21. doi: 10.1002/jmv.21532.

Late neurotoxicity after nasopharyngeal carcinoma treatment.
Siala W, Mnejja W, Khabir A, Ben Mahfoudh K, Boudawara T, Ghorbel A, Frikha M, Daoud J.
Cancer Radiother. 2009 Dec;13(8):709-14. doi: 10.1016/j.canrad.2009.05.006. Epub 2009 Aug 19. French.

Prognostic value of parapharyngeal extension in nasopharyngeal carcinoma
Nasr Ben Ammar C, Kochbati L, Lejri N, Chaouache K, Frikha H, Besbes M, Touati S, Ben Abdallah M, Maalej M.
Tunis Med. 2009 Dec;87(12):814-7. French.

IgA antibodies against the Epstein-Barr nuclear antigen1 as a valuable biomarker for the diagnosis of nasopharyngeal carcinoma in Tunisian patients.
Ayadi W, Karray-Hakim H, Feki L, Khabir A, Boudawara T, Ghorbel A, Daoud J, Frikha M, Hammami A.
J Med Virol. 2009 Aug;81(8):1412-21. doi: 10.1002/jmv.21532.

A case of thyroid metastasis of an unusual cancer
Dhouib H, Ben Hmida A, Daoud J, Frikha M, Charfeddine I, Ghorbel A.
Cancer Radiother. 2009 Jun;13(3):213-5. doi: 10.1016/j.canrad.2009.01.004. Epub 2009 Mar 26. French.

Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
Fendri A, Masmoudi A, Khabir A, Sellami-Boudawara T, Daoud J, Frikha M, Ghorbel A, Gargouri A, Mokdad-Gargouri R.
Cancer Biol Ther. 2009 Mar;8(5):444-51. Epub 2009 Mar 21.